The FDA Is Finally Pulling a Useless Cold Medicine From the Market
And finally, the agency is making plans to pull it from pharmacy and grocery store shelves.The medicines will remain ...
McKnight's Long-Term Care News11d
FDA approves new antibiotic for uncomplicated UTIs
The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections ...
Food Safety News6d
FDA issues warning letters to mushroom and produce importers for critical safety violations
Though the company provided some records, FDA noted that these documents lacked clarity and approval by qualified FSVP personnel. Paso Real Produce LLC, based in Pharr, TX, received an FDA warning ...
The New Republic on MSN1dOpinion
RFK Jr. Has Terrifying Plan for First Day in Trump’s Administration
Robert F. Kennedy Jr., the anti-vaccine conspiracy theorist Donald Trump promised would be given free rein over America’s ...
Lexicon Pharmaceuticals Halted All Day as FDA Panel Reviews Zynquista
Lexicon Pharmaceuticals shares have been halted all day as a Food and Drug Administration advisory committee was scheduled to vote on Zynquista as an adjunct to insulin therapy for glycemic control in ...
policymed.com12d
FDA Releases Draft Guidance on Randomized Controlled Drug Trials in Routine Clinical Practice
Recently, the United States Food and Drug Administration (FDA) issued a draft guidance, Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice ...
Medscape4d
Last Month in Oncology: FDA Cancer News Roundup
The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...
The American Journal of Managed Care3d
FDA Q&A: Addressing Biosimilar Safety, AI in Drug Development, and Supply Chain Challenges
In a Q&A, an FDA spokesperson discusses efforts to reduce misinformation about biosimilars through education, the agency’s ...
Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution
Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time ...
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
RYTELOâ„¢ (imetelstat) is FDA approved for the treatment of low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent ...
MedPage Today11d
FDA Staff Not Quite Sold on Sotagliflozin for T1D Patients With CKD
In the briefing documents, FDA's reviewers again raised concerns ... The SGLT1/SGLT2 inhibitor last year gained approval (marketed as Inpefa) to reduce the risk of cardiovascular death and urgent ...